Purchasing Tips: Key Factors for Glucagon HCl Injection Quality
Abstract: Glucagon HCl injection quality hinges on peptide purity (>98% by HPLC), stability, and regulatory compliance. Market trends show 7.2% CAGR growth driven by diabetes and hypoglycemia management. Leading brands (Eli Lilly, Novo Nordisk) offer lyophilized vs. liquid formulations; lyophilized ensures longer shelf life (24–36 months) but requires reconstitution. Key parameters: pH (2.5–3.5), potency (≥95% of label claim), and endotoxin limits (<0.5 EU/mg). Certifications (GMP, USP, FDA) are critical. Logistics require cold chain (2–8°C) and moisture-proof packaging. Selection tips: verify batch-specific COAs, compare excipient profiles (e.g., lactose vs. mannitol), and audit manufacturer’s peptide synthesis technology (solid-phase vs. recombinant). Industry outlook: biosimilar competition and prefilled auto-injectors dominate innovation.